These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 19729451)
21. [ADAMTS13, von Willebrand factor specific cleaving protease]. Veyradier A; Coppo P Med Sci (Paris); 2011 Dec; 27(12):1097-105. PubMed ID: 22192749 [TBL] [Abstract][Full Text] [Related]
22. Degradation of circulating von Willebrand factor and its regulator ADAMTS13 implicates secreted Bacillus anthracis metalloproteases in anthrax consumptive coagulopathy. Chung MC; Popova TG; Jorgensen SC; Dong L; Chandhoke V; Bailey CL; Popov SG J Biol Chem; 2008 Apr; 283(15):9531-42. PubMed ID: 18263586 [TBL] [Abstract][Full Text] [Related]
23. A conformation-sensitive monoclonal antibody against the A2 domain of von Willebrand factor reduces its proteolysis by ADAMTS13. Zhang J; Ma Z; Dong N; Liu F; Su J; Zhao Y; Shen F; Wang A; Ruan C PLoS One; 2011; 6(7):e22157. PubMed ID: 21779388 [TBL] [Abstract][Full Text] [Related]
24. Cleavage of von Willebrand factor requires the spacer domain of the metalloprotease ADAMTS13. Zheng X; Nishio K; Majerus EM; Sadler JE J Biol Chem; 2003 Aug; 278(32):30136-41. PubMed ID: 12791682 [TBL] [Abstract][Full Text] [Related]
25. Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers. Nolasco LH; Turner NA; Bernardo A; Tao Z; Cleary TG; Dong JF; Moake JL Blood; 2005 Dec; 106(13):4199-209. PubMed ID: 16131569 [TBL] [Abstract][Full Text] [Related]
26. Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow. Bernardo A; Ball C; Nolasco L; Moake JF; Dong JF Blood; 2004 Jul; 104(1):100-6. PubMed ID: 15026315 [TBL] [Abstract][Full Text] [Related]
27. Generation and breakdown of soluble ultralarge von Willebrand factor multimers. Turner N; Nolasco L; Moake J Semin Thromb Hemost; 2012 Feb; 38(1):38-46. PubMed ID: 22314602 [TBL] [Abstract][Full Text] [Related]
28. In vivo imaging analysis of the interaction between unusually large von Willebrand factor multimers and platelets on the surface of vascular wall. Rybaltowski M; Suzuki Y; Mogami H; Chlebinska I; Brzoska T; Tanaka A; Banno F; Miyata T; Urano T Pflugers Arch; 2011 Jun; 461(6):623-33. PubMed ID: 21494805 [TBL] [Abstract][Full Text] [Related]
29. Binding of von Willebrand factor cleaving protease ADAMTS13 to Lys-plasmin(ogen). Shin Y; Akiyama M; Kokame K; Soejima K; Miyata T J Biochem; 2012 Sep; 152(3):251-8. PubMed ID: 22685231 [TBL] [Abstract][Full Text] [Related]
30. Ultralarge von Willebrand factor multimers and normal ADAMTS13 activity in the umbilical cord blood. Tsai HM; Sarode R; Downes KA Thromb Res; 2002 Nov; 108(2-3):121-5. PubMed ID: 12590947 [TBL] [Abstract][Full Text] [Related]
31. Identification of ADAMTS13 peptide sequences binding to von Willebrand factor. Moriki T; Maruyama IN; Igari A; Ikeda Y; Murata M Biochem Biophys Res Commun; 2010 Jan; 391(1):783-8. PubMed ID: 19944670 [TBL] [Abstract][Full Text] [Related]
33. Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation. Reiter RA; Varadi K; Turecek PL; Jilma B; Knöbl P Thromb Haemost; 2005 Mar; 93(3):554-8. PubMed ID: 15735809 [TBL] [Abstract][Full Text] [Related]
34. Effect of tranexamic acid on endothelial von Willebrand factor/ADAMTS-13 response to in vitro shock conditions. Diebel LN; Liberati DM J Trauma Acute Care Surg; 2023 Feb; 94(2):273-280. PubMed ID: 36322025 [TBL] [Abstract][Full Text] [Related]
35. Mechanistic studies on ADAMTS13 catalysis. Di Stasio E; Lancellotti S; Peyvandi F; Palla R; Mannucci PM; De Cristofaro R Biophys J; 2008 Sep; 95(5):2450-61. PubMed ID: 18502798 [TBL] [Abstract][Full Text] [Related]
36. [Increased susceptibility of recombinant type 2A von Willebrand factor mutant A1500E to proteolysis by ADAMTS13]. Zhang JY; Su J; Ma ZN; Dong NZ; Wang YC; Ruan CG Zhonghua Xue Ye Xue Za Zhi; 2012 Mar; 33(3):169-72. PubMed ID: 22781599 [TBL] [Abstract][Full Text] [Related]
37. ADAMTS13 cleavage efficiency is altered by mutagenic and, to a lesser extent, polymorphic sequence changes in the A1 and A2 domains of von Willebrand factor. Pruss CM; Notley CR; Hegadorn CA; O'Brien LA; Lillicrap D Br J Haematol; 2008 Nov; 143(4):552-8. PubMed ID: 18986390 [TBL] [Abstract][Full Text] [Related]
38. Von Willebrand factor and ADAMTS13 in arterial thrombosis: a systematic review and meta-analysis. Sonneveld MA; de Maat MP; Leebeek FW Blood Rev; 2014 Jul; 28(4):167-78. PubMed ID: 24825749 [TBL] [Abstract][Full Text] [Related]
39. Ultralarge von Willebrand factor fibers mediate luminal Staphylococcus aureus adhesion to an intact endothelial cell layer under shear stress. Pappelbaum KI; Gorzelanny C; Grässle S; Suckau J; Laschke MW; Bischoff M; Bauer C; Schorpp-Kistner M; Weidenmaier C; Schneppenheim R; Obser T; Sinha B; Schneider SW Circulation; 2013 Jul; 128(1):50-9. PubMed ID: 23720451 [TBL] [Abstract][Full Text] [Related]
40. The potential therapeutic benefit of targeting ADAMTS13 activity. Eerenberg ES; Levi M Semin Thromb Hemost; 2014 Feb; 40(1):28-33. PubMed ID: 24338607 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]